Kory James Wentworth - Mar 15, 2024 Form 4 Insider Report for Entrada Therapeutics, Inc. (TRDA)

Role
Chief Financial Officer
Signature
/s/ Jared Cohen, as Attorney-in-Fact
Stock symbol
TRDA
Transactions as of
Mar 15, 2024
Transactions value $
$18,900
Form type
4
Date filed
3/19/2024, 04:33 PM
Previous filing
Mar 8, 2024
Next filing
Jul 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TRDA Common Stock Options Exercise $18.9K +9K +12.13% $2.10 83.2K Mar 15, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRDA Stock Option (Right to Buy) Options Exercise $0 -9K -17.26% $0.00 43.2K Mar 15, 2024 Common Stock 9K $2.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to this option shall vest and become exercisable on November 16, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter.